Alira Health, a provider of cloud-based hybrid and decentralized clinical trial solutions for life sciences research companies, secured an additional $58 million in equity funding. The company did not disclose the investors.
To date, including the most recent fundraising round, Alira Health has raised $133 in venture capital funding. The company raised $35 million in 2021 and $40 million in 2022, in two separate funding rounds led by Creadev.
Commenting on the funding round, Gabriele Brambilla, CEO and Co-Founder of Alira Health, said: We are executing on our winning strategy to become a patient-centric solutions provider, enabled by innovative technologies that will collect clinical and real-world data directly from patients, powerfully informing the development of new drugs and devices.”
Benjamin Chambon, CCO and Co-founder of Alira Heath, said: “Patient data will illuminate the patient journey for life sciences companies, guiding the direction of research and development. The result will be the democratization of life sciences research.”
Digital clinical trial startups have raised almost $2 billion in funding to date, according to our database. More recently, Lokavant, a provider of a clinical trial data intelligence and analytics platform, raised $21 million in funding led by Edison Partners with participation from Roivant Sciences. In another deal, YonaLink, a provider of clinical trial data collection and validation software platform, raised $6 million in funding led by Debiopharm Innovation Fund in Switzerland with the European Union and Israel’s eHealth Ventures.
